PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada.\', \'Division of Immunology/Allergy, The Hospital for Sick Children, Toronto, Ontario, Canada.\', \'Paediatric Medicine Division, The Hospital for Sick Children, Toronto, Ontario, Canada.\', \'Corporate Strategy & Performance, The Hospital for Sick Children, Toronto, Ontario, Canada.\', \'Department of Surgery, The Hospital for Sick Children, Toronto, Ontario, Canada.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1002/pbc.29295
?:hasPublicationType
?:journal
  • Pediatric blood & cancer
is ?:pmid of
?:pmid
?:pmid
  • 34398511
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Safety of administration of BNT162b2 mRNA (Pfizer-BioNTech) COVID-19 vaccine in youths and young adults with a history of acute lymphoblastic leukemia and allergy to PEG-asparaginase.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34398511>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34398511>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all